Praxis Precision Medicines, Inc.(PRAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRAX Praxis Precision Medicines, Inc.

Pre-Mkt 08-06 04:54:40 EDT

319.23

+9.16

+2.95%

High320.68	Low308.17	Vol274.91K
Open315.00	D1 Closing310.07	Amplitude4.03%
Mkt Cap8.89B	Tradable Cap7.67B	Total Shares27.85M
T/O87.14M	T/O Rate1.14%	Tradable Shares24.01M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PRAX","market":"US","secType":"STK","nameCN":"Praxis Precision Medicines, Inc.","latestPrice":319.23,"timestamp":1785960000000,"preClose":310.07,"halted":0,"volume":274906,"delay":0,"changeRate":0.029541716386622455,"floatShares":24012900,"shares":27850833,"eps":-13.34879,"marketStatus":"Pre-Mkt","change":9.16,"latestTime":"08-06 04:54:40 EDT","open":315,"high":320.68,"low":308.17,"amount":87135261.39904,"amplitude":0.040346,"askPrice":350.99,"askSize":2,"bidPrice":315.01,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-13.34879,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1786023000000},"marketStatusCode":1,"adr":0,"listingDate":1602820800000,"exchange":"NASDAQ","adjPreClose":319.23,"postHourTrading":{"tag":"盘后","latestPrice":322,"preClose":319.23,"latestTime":"19:55 EDT","volume":2408,"amount":768905.888,"timestamp":1785974116174,"change":2.77,"changeRate":0.008677,"amplitude":0.008677},"volumeRatio":0.7299513302274804,"impliedVol":0.6305,"impliedVolPercentile":0.068},"requestUrl":"/m/hq/s/PRAX","defaultTab":"news","newsList":[{"id":"2657693385","title":"Praxis Precision Medicines Grants 7,318 RSUs to 29 New Employees Under 2024 Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2657693385","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657693385?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:02","pubTimestamp":1785873760,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines grants 7,318 RSUs to 29 new employees under 2024 inducement planPraxis Precision Medicines granted restricted stock units covering 7,318 common shares to 29 new non-executiv","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL2Gq3xh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BK4585","BK4588","IE0002141913.USD","LU0320765992.SGD","IBRN","LU0314104364.USD","IE00B64PRP62.GBP","PRAX","SG9999014039.USD","BCDF","IE00BKPKM429.USD","IE0009355771.USD","SG9999014021.USD","LU2210149790.SGD","IE00BN0W2T93.GBP","BK4112","SG9999014005.SGD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","BK4139","LU2095319765.USD","IE00BN0W2W23.USD","IE00B4R5TH58.HKD","IE00BN0W2V16.EUR","LU2210150020.SGD","NDAQ","IE00B2B36J28.USD","IE00BGHQF748.EUR","LU0889565916.HKD","LU0109394709.USD","SG9999014013.SGD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657791566","title":"Praxis Precision Medicines, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657791566","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657791566?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:01","pubTimestamp":1785873661,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nTUABCBZ25:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","BK4139","IE00B2B36J28.USD","PRAX","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU0889565916.HKD","IE0002141913.USD","LU0109394709.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657678635","title":"Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657678635","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657678635?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:01","pubTimestamp":1785873660,"startTime":"0","endTime":"0","summary":"Investor Contact:. 857-702-9452. Media Contact:. Dan Ferry. LifeSci Advisors. 617-430-7576","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/04/3338776/0/en/Praxis-Precision-Medicines-Inc-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE0009355771.USD","IE00B4R5TH58.HKD","BK4561","PRAX","BK4139","ASO","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4200","BK4135","LU0109394709.USD","CNS","LCLG","LU0889565916.HKD","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656590215","title":"Praxis Precision Medicines Inc Expected to Post a Loss of $3.66 a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656590215","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656590215?lang=en_us&edition=fundamental","pubTime":"2026-08-04 21:18","pubTimestamp":1785849486,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines Inc <PRAX.OQ> expected to post a loss of $3.66 a share - Earnings PreviewPraxis Precision Medicines IncPRAX.OQPRAX.Ois expected to  show no change in quarterly revenue when ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N4411OR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","LU0109394709.USD","IE0002141913.USD","PRAX","LU0889565916.HKD","IE00B2B36J28.USD","BK4139","IBRN","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656303694","title":"Praxis Extends Vormatrogine Epilepsy Trial, Keeping Long-Term Growth Story in Play","url":"https://stock-news.laohu8.com/highlight/detail?id=2656303694","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656303694?lang=en_us&edition=fundamental","pubTime":"2026-08-04 00:32","pubTimestamp":1785774777,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines, Inc. ($PRAX) announced an update on their ongoing clinical study. Praxis Precision Medicines is running an extension st...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/praxis-extends-vormatrogine-epilepsy-trial-keeping-long-term-growth-story-in-play?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/praxis-extends-vormatrogine-epilepsy-trial-keeping-long-term-growth-story-in-play?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBRN","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4139","IE0002141913.USD","IE00B2B36J28.USD","PRAX","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656036353","title":"Praxis Advances PRAX-628 Tablet Formulation in Completed Bioavailability Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2656036353","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656036353?lang=en_us&edition=fundamental","pubTime":"2026-08-04 00:30","pubTimestamp":1785774621,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines, Inc. ($PRAX) announced an update on their ongoing clinical study. Praxis PRAX-628 Trial Shows Progress on Next-Gen Epil...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/praxis-advances-prax-628-tablet-formulation-in-completed-bioavailability-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/praxis-advances-prax-628-tablet-formulation-in-completed-bioavailability-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B4R5TH58.HKD","BK4139","PRAX","IE0002141913.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","IE00BJT1NW94.SGD","LU0320765992.SGD","LU0889565916.HKD","IBRN","IE0009355771.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655786130","title":"Praxis Precision Med Price Target Maintained with a $810.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2655786130","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655786130?lang=en_us&edition=fundamental","pubTime":"2026-07-29 18:41","pubTimestamp":1785321660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRAX/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","IE00BJJMRZ35.SGD","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","IE00B2B36J28.USD","IE0002141913.USD","PRAX","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","IE00B4R5TH58.HKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653225074","title":"Praxis Precision Medicines (PRAX) Has a New Rating from Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2653225074","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653225074?lang=en_us&edition=fundamental","pubTime":"2026-07-21 13:15","pubTimestamp":1784610921,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Kevin Strang initiated coverage with a Buy rating on Praxis Precision Medicines on July 17 and set a price target of $447.00....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/praxis-precision-medicines-prax-has-a-new-rating-from-goldman-sachs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/praxis-precision-medicines-prax-has-a-new-rating-from-goldman-sachs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652261765","title":"Praxis Precision Medicines (PRAX) Could Be 49% Undervalued As Patch Deal Expands Ulixacaltamide Reach","url":"https://stock-news.laohu8.com/highlight/detail?id=2652261765","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652261765?lang=en_us&edition=fundamental","pubTime":"2026-07-20 11:30","pubTimestamp":1784518237,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines (PRAX) drew fresh investor attention after announcing a research collaboration and license agreement with Remagine Labs to develop a multi day iontophoretic transdermal patch for ulixacaltamide in essential tremor.\nSee our latest analysis for Praxis Precision Medicines.\nThe latest collaboration news arrives after a period of mixed momentum for Praxis Precision Medicines, with the share price up 11.37% over 30 days but down 8.22% over 90 days, while the 1 year total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prax/praxis-precision-medicines/news/praxis-precision-medicines-prax-could-be-49-undervalued-as-p","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prax/praxis-precision-medicines/news/praxis-precision-medicines-prax-could-be-49-undervalued-as-p","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0109394709.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","PRAX","IBRN","LU0889565916.HKD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0320765992.SGD","IE00B4R5TH58.HKD","BK4139","IE00B2B36J28.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651143954","title":"Analysts Conflicted on These Healthcare Names: Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Medicines (PRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651143954","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651143954?lang=en_us&edition=fundamental","pubTime":"2026-07-14 00:10","pubTimestamp":1783959019,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Me...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alkermes-alks-transmedics-group-tmdx-and-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alkermes-alks-transmedics-group-tmdx-and-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","IE00B4R5TH58.HKD","LU0109394709.USD","LU2065731478.USD","BK4139","IE00BFTCPJ56.SGD","BK4581","LU2324357040.USD","LU0320765992.SGD","IE0009355771.USD","XBI","BK4082","IE0002141913.USD","LU0889565916.HKD","LABU","BK4588","TMDX","IBRN","ALKS","IE00BJJMRZ35.SGD","BK4585","IE00BJT1NW94.SGD","LU0128526141.USD","HCSG","XLV","MEDX","PSCH","IE00B2B36J28.USD","BK4137","PSIL","PRAX","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651111442","title":"Analysts Are Bullish on Top Healthcare Stocks: Praxis Precision Medicines (PRAX), Sino Biopharmaceutical (SBMFF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651111442","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651111442?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:40","pubTimestamp":1783946410,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Praxis Precision Medicines (PRAX), Sino Biopharmaceu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-praxis-precision-medicines-prax-sino-biopharmaceutical-sbmff-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-praxis-precision-medicines-prax-sino-biopharmaceutical-sbmff-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","PRAX","BK4139","IE00BFTCPJ56.SGD","BK4007","IE00BJJMRZ35.SGD","SBMFF","IE00B2B36J28.USD","LU0889565916.HKD","IE0009355771.USD","IE0002141913.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0109394709.USD","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651164621","title":"Goldman Sachs Initiates Praxis Precision Medicines at Buy With $447 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2651164621","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651164621?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:37","pubTimestamp":1783942662,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines (PRAX) has an average rating of buy and mean price target of $604.84, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651116903","title":"S&P 500 Futures Decline in Premarket Trading; SK Hynix ADR, MKS Lag","url":"https://stock-news.laohu8.com/highlight/detail?id=2651116903","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651116903?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:30","pubTimestamp":1783942200,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Barrons.com using technology from Automated Insights.With U.S. stock markets set to open in two hours, Praxis Precision Medicines Inc. (PRAX) was up 5.9% in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNDR","TSPA","SPYM","OALC","MKSI","FLCC","CDP","TXT","FLAO","HELO","FEBT","XUSP","GBXB","PTL","CFO","BKLC","DINT","DIVL",".SPX","GSUS","ISSXF","SCHG","SPYD","UOCT","PBJL","RAM","ACLC","UXJA","PTLC","CPST","SKHX","VUG","CVY","LGH","SK","APIE","AADR","VYM","GPIX","VOO","XPAY","SKHY","VOOG","SPY","SAPH","MYRG","MRCP","CGUS","FELC","PRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651793190","title":"Praxis Precision Med Initiated at Buy by Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2651793190","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651793190?lang=en_us&edition=fundamental","pubTime":"2026-07-13 17:52","pubTimestamp":1783936320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRAX/analyst-ratings(END) Dow Jones NewswiresJuly 13, 2026 05:52 ET","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","LU1868837136.USD","BK4588","LU0096364046.USD","LU1791807156.HKD","LU0868494708.USD","LU0742534661.SGD","LU2471134952.CNY","IBRN","LU2237443465.HKD","LU2265009873.SGD","BK4552","BK4533","LU0061475181.USD","LU0251131958.USD","LU2237438978.USD","LU2237443382.USD","IE00BJT1NW94.SGD","LU1894683264.USD","IE00B19Z3581.USD","IE0004086264.USD","LU0320765992.SGD","LU2471134879.HKD","LU2237443549.SGD","IE00BFXG1179.USD","PRAX","LU1668664300.SGD","LU0251142724.SGD","LU2471134796.USD","IE00B19Z3B42.SGD","IE0004091025.USD","IE00B2B36J28.USD","LU1868836591.USD","BK4516","IE0009355771.USD","LU0868494617.USD","IE0034235188.USD","LU1868836914.USD","LU0109394709.USD","BK4139","IE00BFTCPJ56.SGD","LU0889565916.HKD","LU2471134523.USD","IE0002270589.USD","GSX","LU1868836757.USD","LU2237443622.USD","BK4504","IE00BSNM7G36.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651190997","title":"Praxis Precision initiated with a Buy at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2651190997","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651190997?lang=en_us&edition=fundamental","pubTime":"2026-07-13 17:25","pubTimestamp":1783934704,"startTime":"0","endTime":"0","summary":"Goldman Sachs initiated coverage of Praxis Precision (PRAX) with a Buy rating and $447 price target Praxis is a clinical-stage biotech company with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/praxis-precision-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/praxis-precision-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","LU2750360641.GBP","IE00B19Z3B42.SGD","LU1868836591.USD","IE00BJT1NW94.SGD","LU0742534661.SGD","LU1868837136.USD","LU1894683348.USD","BK4139","IE00BSNM7G36.USD","LU2237443465.HKD","IE00B4R5TH58.HKD","BK4588","LU0048573561.USD","BK4550","LU2237443622.USD","GSX","LU2750360997.AUD","IE0004086264.USD","IE00BFTCPJ56.SGD","LU2237443382.USD","LU1894683264.USD","LU0889565916.HKD","IE0034235188.USD","IE0002141913.USD","IE0004091025.USD","LU1804176565.USD","LU1868836914.USD","IE00B2B36J28.USD","LU0868494708.USD","BK4504","IE00BFXG1179.USD","LU2471134523.USD","LU2471134796.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","BBC","BK4516","BK4552","LU0345770993.USD","LU0942090050.USD","LU1791807156.HKD","LU0061475181.USD","BK4127","IBRN","LU0106831901.USD","LU2237443549.SGD","LU2237438978.USD","LU0345770308.USD","PRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650539921","title":"RBC Capital Remains a Buy on Praxis Precision Medicines (PRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650539921","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650539921?lang=en_us&edition=fundamental","pubTime":"2026-07-11 09:47","pubTimestamp":1783734474,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Leonid Timashev maintained a Buy rating on Praxis Precision Medicines yesterday and set a price target of $449.00. According to...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0029864427.USD","IE0002141913.USD","LU0128525929.USD","IE00B2B36J28.USD","GSIB","BK4139","LU1267930573.SGD","IE00BJJMRZ35.SGD","LU0320765992.SGD","BK4207","PRAX","IE00B4R5TH58.HKD","LU0109394709.USD","LU0310800379.SGD","IE0009355771.USD","IBRN","LU0708994859.HKD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650133950","title":"Can Praxis Precision Medicines (PRAX) Merit A Higher Valuation As It Expands Ulixacaltamide Delivery?","url":"https://stock-news.laohu8.com/highlight/detail?id=2650133950","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650133950?lang=en_us&edition=fundamental","pubTime":"2026-07-10 20:29","pubTimestamp":1783686555,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines (PRAX) has entered into a research collaboration and license agreement with Remagine Labs to develop an iontophoretic transdermal patch for ulixacaltamide, extending its essential tremor program beyond the existing oral approach.\nSee our latest analysis for Praxis Precision Medicines.\nThe collaboration news lands after a strong run in Praxis Precision Medicines' share price, with a 30 day share price return of 33.07% and year to date share price return of 16.31%,...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prax/praxis-precision-medicines/news/can-praxis-precision-medicines-prax-merit-a-higher-valuation","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prax/praxis-precision-medicines/news/can-praxis-precision-medicines-prax-merit-a-higher-valuation","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BJJMRZ35.SGD","LU0889565916.HKD","LU0320765992.SGD","IE00B4R5TH58.HKD","PRAX","IE00B2B36J28.USD","LU0109394709.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE0002141913.USD","BK4139","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650803221","title":"Praxis Precision Medicines Seen Having Greater Commercial Upside for Relutrigine, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2650803221","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650803221?lang=en_us&edition=fundamental","pubTime":"2026-07-10 20:18","pubTimestamp":1783685933,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines  could see greater commercial upside from its relutrigine epilepsy program as the rare epilepsy market may support premium pricing for the therapy, RBC Capital Markets said in a Friday note.The firm said discussions with management and a review of existing developmental and epileptic encephalopathy therapies suggest relutrigine could sustain a list price of about $450,000 to $650,000.RBC said the higher price could result in stricter payer requirements and initially limit use to patients with more severe disease. Even so, the firm now projects relutrigine revenue of about $2.6 billion by 2035, above the consensus estimate of about $2.45 billion.The firm also said management has not yet decided the path forward for vormatrigine following the recent POWER1 setback, although it continues to evaluate the program.RBC maintained its outperform rating on Praxis Precision Medicines and its $449 price target.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0109394709.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU0889565916.HKD","IBRN","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4139","IE00B4R5TH58.HKD","PRAX","IE0009355771.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649584149","title":"Praxis Precision, Remagine Labs Partner on Ulixacaltamide Patch","url":"https://stock-news.laohu8.com/highlight/detail?id=2649584149","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649584149?lang=en_us&edition=fundamental","pubTime":"2026-07-08 05:31","pubTimestamp":1783459891,"startTime":"0","endTime":"0","summary":"An update from Praxis Precision Medicines ( ($PRAX) ) is now available. On July 7, 2026, Praxis Precision Medicines announced a research collaborat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/praxis-precision-remagine-labs-partner-on-ulixacaltamide-patch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/praxis-precision-remagine-labs-partner-on-ulixacaltamide-patch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","BK4139","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0889565916.HKD","LU0320765992.SGD","PRAX","IBRN","LU0109394709.USD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649565987","title":"Praxis Precision Medicines Makes Equity Investment in Remagine Labs","url":"https://stock-news.laohu8.com/highlight/detail?id=2649565987","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649565987?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:03","pubTimestamp":1783425783,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines makes equity investment in Remagine LabsPraxis Precision Medicines made an equity investment in Remagine Labs to accelerate a collaboration on transdermal ulixacaltamide for","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDLb4Gx0f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","IE00BJJMRZ35.SGD","LU0109394709.USD","IE00B2B36J28.USD","IE00BN0W2T93.GBP","IE00BKPKM429.USD","NDAQ","IE00B4R5TH58.HKD","IBRN","LU0314104364.USD","IE0009355771.USD","SG9999014021.USD","IE00B3QW5Z07.USD","IE00BFTCPJ56.SGD","LU2210149790.SGD","BK4139","IE00BN0W2V16.EUR","SG9999014013.SGD","LU2210150020.SGD","BK4112","SG9999014005.SGD","LU0320765992.SGD","PRAX","LU0889565916.HKD","BCDF","IE00B64PRP62.GBP","LU2095319765.USD","IE0002141913.USD","IE00BJT1NW94.SGD","SG9999014039.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.praxismedicines.com","stockEarnings":[{"period":"1week","weight":0.0969},{"period":"1month","weight":0.0183},{"period":"3month","weight":-0.0422},{"period":"6month","weight":-0.0011},{"period":"1year","weight":5.6798},{"period":"ytd","weight":0.0831}],"compareEarnings":[{"period":"1week","weight":0.0553},{"period":"1month","weight":0.0246},{"period":"3month","weight":0.0522},{"period":"6month","weight":0.1146},{"period":"1year","weight":0.2258},{"period":"ytd","weight":0.1289}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is developing ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase IIb clinical trial for the treatment of essential tremor, as well as in Phase II clinical trial to treat Parkinson's disease; PRAX-562 for the treatment of pediatric patients with developmental and epileptic encephalopathies (DEE); and PRAX-628 to treat focal epilepsy. The company also develops PRAX-222 for the treatment of pediatric patients with early-onset SCN2A-DEE; PRAX-020 to treat KCNT1 related epilepsies; PRAX-080 for the treatment of PCDH19; and PRAX-090 and PRAX-100 for SYNGAP1 and SCN2A-LoF. It has a license agreement with RogCon Inc.; a research collaboration and license agreement with Ionis Pharmaceuticals, Inc.; a strategic collaboration and license agreement with UCB Biopharma SRL; and collaboration with The Florey Institute to develop three novel ASOs. Praxis Precision Medicines, Inc. was incorporated in 2015 and is based in Boston, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.298328},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.166549},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.160217},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.017086},{"month":5,"riseRate":0.5,"avgChangeRate":-0.087139},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.085881},{"month":7,"riseRate":0.5,"avgChangeRate":0.12656},{"month":8,"riseRate":0.5,"avgChangeRate":0.073367},{"month":9,"riseRate":0.6,"avgChangeRate":0.013557},{"month":10,"riseRate":0.6,"avgChangeRate":0.512334},{"month":11,"riseRate":0.666667,"avgChangeRate":0.073478},{"month":12,"riseRate":0.833333,"avgChangeRate":0.206625}],"exchange":"NASDAQ","name":"Praxis Precision Medicines, Inc.","nameEN":"Praxis Precision Medicines, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Praxis Precision Medicines, Inc.(PRAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Praxis Precision Medicines, Inc.(PRAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Praxis Precision Medicines, Inc.,PRAX,Praxis Precision Medicines, Inc.股票,Praxis Precision Medicines, Inc.股票老虎,Praxis Precision Medicines, Inc.股票老虎国际,Praxis Precision Medicines, Inc.行情,Praxis Precision Medicines, Inc.股票行情,Praxis Precision Medicines, Inc.股价,Praxis Precision Medicines, Inc.股市,Praxis Precision Medicines, Inc.股票价格,Praxis Precision Medicines, Inc.股票交易,Praxis Precision Medicines, Inc.股票购买,Praxis Precision Medicines, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Praxis Precision Medicines, Inc.(PRAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Praxis Precision Medicines, Inc.(PRAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction